CRITERIOS DE USO RACIONAL DE ANTIBIÓTICOS
“RECOMENDACIONES
PARA UN USO RACIONAL DE LOS ANTIBIÓTICOS EN EL TRATAMIENTO DE LAS
INFECCIONES URINARIAS”
Dr. Santiago Grau Cerrato. Servicio de Farmacia. IMAS. Hospital del Mar
(Barcelona)
BIBLIOGRAFÍA
1. Chambers
HF, Sande MA. Antimicrobial agents. General considerations. In: Hardman
JG, Limbird LE, eds. Goodman and Gilman’s. The Pharmacological basis
of therapeutics. New York: McGraw Hill, 1996:1029-56.
2. Moellering RC. Principles of anti-infective therapy. In: Mandell GL,
Bennet JE, Dolin R, eds. Principles and practice of infectious diseases.
New York: Churchill Livingstone, 1995:199-212.
3. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE.
Guidelines for antimicrobial treatment of uncomplicated acute bacterial
cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29:745-58.
4. Kahlmeter G. The ECO-SENS Project: a prospective, multinational, multicentre
epidemiological survey of the prevalence and antimicrobial susceptibility
of urinary tract pathogens-interim report. J Antimicrob Chemother 2000;46(suppl
S1):15-22.
5. Fihn SD. Acute uncomplicated tract infection in women. N Engl J Med
2003; 349:259-66.
6. Del Río Pérez G. Tratamiento de las infecciones urinarias.
En: En Drobnic L, ed. Tratamiento antimicrobiano. Madrid: EMISA, 1997:429-43.
7. Zinner SH, Mayer KH. Antibacterial Chemotherapy. In: Kass EH, PlattR,
eds. Current Therapy in Infections Disease-3. Toronto: BC Decker Inc,
1990:6-11.
8. Greenwood D. Fosfomycin and fosmidomycin. In: O’Grady F, Lambert
HP, Finch RG, Greenwood D, eds. Antibiotic and Chemotherapy. New York:
Churchill Livingstone, 1997:357-9.
9. Krieger JN. Urinary tract infections: What’s new?. J Urol 2002;
168:2351-8.
10. Kahlmeter G. An international survey of the antimicrobial susceptibility
of pathogens from uncomplicated urinary tract infections: the ECO.SENS
Project. J Antimicrob Chemother 2003; 51:69-76.
11. Kahlmeter G, Menday P. Cross-resistance and associated resistance
in 2478 Escherichia coli isolates from the Pan-European ECO.SENS project
surveying the antimicrobial susceptibility of pathogens from uncomplicated
urinary tract infections. J Antimicrob Chemother 2003; 52:128-31.
12. Andreu A., J.I. Alós et al y Grupo Cooperativo Español
para el estudio de la Sensibilidad Antimicrobiana de los Patógenos
Urinarios. Etiología y sensibilidad a los antimicrobianos de los
uropatógenos acausantes de la infección urinaria baja adquirida
en la comunidad. Estudio Nacional multicéntrico. Enfer Infecc Microbiol
Clin 2005; 23 (1): 4-9
13. Kahlmeter G. The ECO-SENS Project: a prospective, multinational, multicentre
epidemiological survey of the prevalence and antimicrobial susceptibility
of urinary tract pathogens-interim report. J Antimicrob Chemother 2000;
46(suppl S1):15-22.
14. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett
JE, Dolin R,eds. Principles and practice of infectious diseases. 5th ed.
Philadelphia: Churchill Livingstone, 2000:773-805.
15. Gordon KA, Jones RN. SENTRY Participants Groups (Europe, Latin America,
North America). Susceptibility patterns of orally administered antimicrobials
among urinary tract infection pathogens from hospitalised patients in
North America: a comparison report to Europe abd Latin America. Results
from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol
Infect Dis 2003; 45:295-301.
16. Naber KG. Treatment options for acute uncomplicated cystitis in adults.
J Antimicrob Chemother 2000; 46(suppl 1):23-7.
17. García-Rodríguez JA, Trujillano Martín I, Baquero
F, Cisterna R, Gobernado M, Linares F, et al. In vitro activity of fosfomycin
trometamol against pathogens from urinary tract infections: a Spanish
multicenter study. J Chemother 1997; 9:394-402.
18. Alós JI, Balas D, Gómez JL, y Grupo de Estudio de Infección
en Atención Primaria. Prevalencia de susceptibilidad a quinolonas
y otros antibióticos en microorganismos aislados de bacteriurias
extrahospitalarias de Madrid en 1995. Rev Clin Esp 1997; 197:167-71.
19. Servei Català de la Salut. Butlletí d’informació
terapèutica. Resistències bacterianes als antibiòtics.
12 (5). Mayo 2000.
20. Lindgren PK, Karlsson A, Hughes D. Mutation rate and evolution of
fluoroquinolone resistance in Escherichia coli isolates from patients
with urinary tract infections. Antimicrob Agents Chemother 2003; 47:3222-32.
21. Stapleton A. Prevention of recurrent urinary-tract infections in women.
Lancet 1999;353:7-8.
22. Grau S, Monterde J, Drobnic L, Salvadó M. Management of urinary
tract infections: a comprehensive review.. Pharmacy World and Science
1997; 19:236-45.
23. Dalet F, Del Río G. Infecciones urinarias. Barcelona: ENE publicidad
S.A, 1997.
24. Blázquez J, Silmi A, Delgado JA, Gómez A, Corral J,
Redondo E. Sintomatología de las infecciones del tracto urinario
inferior. En: Resel L, dir. Infecciones urinarias y shock séptico.
Madrid: Servio de publicaciones Universidad Complutense, 1997:105-118.
25. Mccarty JM, Richard G, Huck W, Tucker RM, et al. A randomized trial
of short-course cirprofloxacin, ofloxacin, or trimethoprim/sulfamathoxazole
for the treatment of acute urinary tract infection in women. Am J Med
1999;106:292-9.
|
